Pancreatic ductal adenocarcinoma (PDAC) is one of the most fatal human cancers due to its
complicated genomic instability. PDAC frequently presents at an advanced stage with …

Background Gastrointestinal (GI) cancers are the most common human tumors encountered
worldwide. The majority of GI cancers are unresectable at the time of diagnosis, and in the …

Background: Patients with pancreatic cancer have a poor prognosis apart from the few
suitable for surgery. Photodynamic therapy (PDT) produces localised tissue necrosis but …

Pancreatic cancer (PaCa) is an aggressive malignancy with a high mortality rate and a poor
prognosis. To evaluate treatment outcomes of patients with pancreatic cancer over the past …

A multi-center population-based study in Shanghai, China was performed to explore the
implications for the management of pancreatic cancer by comparing diagnosis and survival …

Objectives Survival improvement for pancreatic cancer has not been observed in the last 4
decades. We report the most up-to-date population-based relative survival (RS) estimates …

We conducted a meta-analysis to analyse the effect of metformin on survival of pancreatic
cancer patients at various stages. We performed a systematic search of PubMed, Embase …

Objectives Pancreatic cancer continues to carry a poor prognosis with survival rates that
have had minimal improvement over the past 4 decades. We report a population-based …

Background Even when resectable pancreatic cancer (PC) is associated with a dismal
prognosis. Initial presentation varies according with primary tumor location. Aim of this …

Studies over 5 decades have examined ABO blood groups and risk of pancreatic cancer in
Western, Asian, and other populations, though no systematic review has been published …